Sudden hearing loss and MTHFR 677C>T/1298A>C gene polymorphisms

被引:27
作者
Capaccio, P
Ottaviani, F
Cuccarini, V
Ambrosetti, U
Fagnani, E
Bottero, A
Cenzuales, S
Cesana, BM
Pignataro, L
机构
[1] Osped Maggiore, IRCCS, Clin ORL1, I-20100 Milan, Italy
[2] Osped Maggiore, IRCCS, Lab Epidemiol, I-20100 Milan, Italy
[3] Polo Univ Vialba, Ctr Transfus, Azienda Osped L Sacco, Milan, Italy
[4] Polo Univ Vialba, Clin Otorinolaringoiat, Milan, Italy
关键词
MTHFR gene polymorphisms; vascular impairment; sudden hearing loss;
D O I
10.1097/01.GIM.0000157817.92509.45
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Purpose: Sudden hearing loss (SHL) can be caused by vascular disorders favoring impaired cochlear perfusion. A number of inherited prothrombotic risk factors have been considered in the pathogenesis of vascular impairment and the possible role of genetic alterations has recently been suggested. We aimed to investigate the relationship between SHL and MTHFR 677 and 1298 gene polymorphisms. Methods: DNA genotyping was performed on peripheral blood leukocytes in 45 SHL patients and 135 controls. Results: Wild-type MTHFR (677CC/1298AA) was significantly more frequent in the controls (P = 0.01), and gene polymorphisms (677CT, 677TT, 1298AC, 1298CC, compound 677CT/1298AC) were significantly more frequent in the patients (P = 0.005; Ptrend = 0.001). Conclusion: These data suggest that MTHFR gene polymorphisms may be considered as risk factors for SHL and participate on vascular impairment related to this disorder. Further studies, based on large series of patients, are needed to definitely assess the role of this prothrombotic factor in the etiopathogenesis of SHL.
引用
收藏
页码:206 / 208
页数:3
相关论文
共 19 条
  • [1] Abbate R, 1998, THROMB HAEMOSTASIS, V79, P727
  • [2] Folate, homocysteine, endothelial function and cardiovascular disease. What is the link?
    Ashfield-Watt, PAL
    Moat, SJ
    Doshi, SN
    McDowell, IFW
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2001, 55 (08) : 425 - 433
  • [3] Low serum folate levels: A risk factor for sudden sensorineural hearing loss?
    Cadoni, G
    Agostino, S
    Scipione, S
    Galli, J
    [J]. ACTA OTO-LARYNGOLOGICA, 2004, 124 (05) : 608 - 611
  • [4] Methylenetetrahydrofolate reductase C677T genotype and venous thromboembolic disease
    Couturaud, F
    Oger, E
    Abalain, JH
    Chenu, E
    Guias, B
    Floch, HH
    Mercier, B
    Mottier, D
    Leroyer, C
    [J]. RESPIRATION, 2000, 67 (06) : 657 - 661
  • [5] Study of MTHFR and MS polymorphisms as risk factors for NTD in the Italian population
    De Marco, P
    Calevo, MG
    Moroni, A
    Arata, L
    Merello, E
    Finnell, RH
    Zhu, HP
    Andreussi, L
    Cama, A
    Capra, V
    [J]. JOURNAL OF HUMAN GENETICS, 2002, 47 (06) : 319 - 324
  • [6] Genest J, 1992, CURR OPIN LIPIDOL, V3, P295
  • [7] Genetic variations observed in arterial and venous thromboembolism - Relevance for therapy, risk prevention and prognosis
    Harrington, DJ
    Malefora, A
    Schmeleva, V
    Kapustin, S
    Papayan, L
    Blinov, M
    Harrington, P
    Mitchell, M
    Savidge, GF
    [J]. CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2003, 41 (04) : 496 - 500
  • [8] Hirano Koji, 1999, Auris Nasus Larynx, V26, P111, DOI 10.1016/S0385-8146(98)00072-8
  • [9] Association between factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations and events of the arterial circulatory system: A meta-analysis of published studies
    Kim, RJ
    Becker, RC
    [J]. AMERICAN HEART JOURNAL, 2003, 146 (06) : 948 - 957
  • [10] Kumar K S D, 2003, J Obstet Gynaecol, V23, P55, DOI 10.1080/0144361021000043263